Sept 20 (Reuters) - Mauna Kea Technologies SAS MKEA.PA :
* MAUNA KEA TECHNOLOGIES ANNOUNCES NEW CLINICAL STUDY AND
RESEARCH
COLLABORATION AGREEMENT WITH THE LUNG CANCER INITIATIVE AT
JOHNSON & JOHNSON
* MAUNA KEA TECHNOLOGIES WILL PARTICIPATE IN A PROSPECTIVE,
MULTI-CENTER, OPEN-LABEL, SINGLE-ARM CLINICAL FEASIBILITY STUDY
LED BY LCI
* STUDY WILL COMBINE NCLE AND ROBOTIC-ASSISTED BRONCHOSCOPY,
USING
BOTH CELLVIZIO AND MONARCH PLATFORM FROM AURIS HEALTH, INC.
* LCI WILL SPONSOR AND FUND STUDY
* LCI WILL PROVIDE TOTAL FUNDING TO COMPANY OF 978,375
EUROS, A
PORTION OF WHICH IS CONTINGENT UPON SUCCESSFUL COMPLETION OF
CERTAIN STUDY ACTIVITIES
* LCI WILL PROVIDE TOTAL FUNDING TO COMPANY OF 978,375 EUROS
Source text for Eikon: ID:nBw71zdSqa
Further company coverage: MKEA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))